In a filing, Regenxbio Inc revealed its Officer VITTAL VASISTA acquired Company’s shares for reported $0.15 million on Dec 30 ’24. In the deal valued at $7.41 per share,20,041 shares were bought.
Then, KARABELAS ARGERIS N sold 10,000 shares, generating $101,052 in total proceeds. Upon selling the shares at $10.11, the Director now owns 11,286 shares.
Before that, KARABELAS ARGERIS N sold 10,000 shares. Regenxbio Inc shares valued at $115,588 were divested by the Director at a price of $11.56 per share. As a result of the transaction, KARABELAS ARGERIS N now holds 11,286 shares, worth roughly $88030.8.
Goldman downgraded its Regenxbio Inc [RGNX] rating to a Neutral from a a Buy in a research note published on February 11, 2025; the price target was decreased to $14 from $38.
Price Performance Review of RGNX
On Tuesday, Regenxbio Inc [NASDAQ:RGNX] saw its stock jump 11.43% to $7.80. Over the last five days, the stock has gained 27.66%. Regenxbio Inc shares have risen nearly 0.91% since the year began. Nevertheless, the stocks have fallen -64.30% over the past one year. While a 52-week high of $23.14 was reached on 01/07/25, a 52-week low of $5.62 was recorded on 03/04/25. SMA at 50 days reached $7.31, while 200 days put it at $10.14.
Levels Of Support And Resistance For RGNX Stock
The 24-hour chart illustrates a support level at 7.11, which if violated will result in even more drops to 6.41. On the upside, there is a resistance level at 8.19. A further resistance level may holdings at 8.57. The Relative Strength Index (RSI) on the 14-day chart is 62.82, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.68, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 3.54%. Stochastics %K at 69.73% indicates the stock is a holding.
How much short interest is there in Regenxbio Inc?
A steep rise in short interest was recorded in Regenxbio Inc stocks on 2025-02-28, dropping by -0.13 million shares to a total of 6.28 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 6.41 million shares. There was a decline of -2.03%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on June 07, 2024 when Goldman began covering the stock and recommended ‘”a Buy”‘ rating along with a $38 price target.
